Providing Insight Into and Mindfulness for Situational Erectile Dysfunction
PRIMED
1 other identifier
interventional
60
1 country
1
Brief Summary
Erectile dysfunction (ED) is among the most common sexual dysfunctions experienced by men, affecting at least one third of men across the lifespan. Although pharmacological treatments are available, adherence to these treatments is poor, suggesting the need for integration of psychological interventions. This study will determine if a 6-session mindfulness-based psychosexual therapy (MBPST) group will be effective and feasible for men with situational ED. This study is adapted from a previously published 4-session MBPST protocol which was found to be beneficial for men with situational ED. Outcomes are measured using self-report questionnaires on sexual functioning/enjoyment, relationship satisfaction, and treatment acceptability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2019
CompletedFirst Posted
Study publicly available on registry
April 10, 2020
CompletedStudy Start
First participant enrolled
April 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 19, 2022
October 1, 2022
4.6 years
June 27, 2019
October 17, 2022
Conditions
Outcome Measures
Primary Outcomes (15)
Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5
(IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire
Change from baseline to immediately post treatment (6 weeks)
Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5
(IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire
Change from baseline to one month post-treatment (10 weeks)
Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5
(IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire
Change from baseline to four months post-treatment (22 weeks)
Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised
(Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale
Change from baseline to immediately post treatment (6 weeks)
Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised
(Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale
Change from baseline to one month post-treatment (10 weeks)
Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised
(Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale
Change from baseline to four months post-treatment (22 weeks)
Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning
(Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale
Change from baseline to immediately post treatment (6 weeks)
Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning
(Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale
Change from baseline to one month post-treatment (10 weeks)
Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning
(Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale
Change from baseline to four months post-treatment (22 weeks)
Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale.
(Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire
Change from baseline to immediately post treatment (6 weeks)
Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale
(Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire
Change from baseline to one month post-treatment (10 weeks)
Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale
(Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire
Change from baseline to four months post-treatment (22 weeks)
Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire
2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.
Change from baseline to immediately post treatment (6 weeks)
Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire
2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.
Change from baseline to one month post-treatment (10 weeks)
Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire
2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.
Change from baseline to four months post-treatment (22 weeks)
Secondary Outcomes (12)
Anxiety Symptoms as measured by Generalized Anxiety Disorder-7
Change from baseline to immediately post treatment (6 weeks)
Anxiety Symptoms as measured by Generalized Anxiety Disorder-7
Change from baseline to one month post-treatment (10 weeks)
Anxiety Symptoms as measured by Generalized Anxiety Disorder-7
Change from baseline to four months post-treatment (22 weeks)
Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15
Change from baseline to immediately post treatment (6 weeks)
Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15
Change from baseline to one month post-treatment (10 weeks)
- +7 more secondary outcomes
Other Outcomes (9)
Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised
Change from baseline to immediately post treatment (6 weeks)
Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised
Change from baseline to one month post-treatment (10 weeks)
Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised
Change from baseline to four months post-treatment (22 weeks)
- +6 more other outcomes
Study Arms (1)
Single Arm
OTHERPatients are compared to themselves before and after the treatment.
Interventions
The group treatment sessions will integrate empirically supported elements of psychoeduation, cognitive behavioural therapy, and mindfulness skills. Each of the six sessions will follow the well-defined manualized treatment protocol. The treatment is adapted from the study team's previous mindfulness-based treatment group (H15-03172), for situational ED which has been shown to be effective. Participants will be provided with handouts and asked to complete approximately 10-60 minutes/day of at-home practice/skills, which may include reading material, mindfulness exercises, and/or behavioural exercises between sessions. During the 2 follow-up sessions, participants will be invited to share their experience since the conclusion of group, ask questions, and participate in troubleshooting.
Eligibility Criteria
You may qualify if:
- This study is open to individuals who are:
- Diagnosed with situational erectile dysfunction (ED) of at least 6 months duration, as assessed by a physician at the BC Centre for Sexual Medicine according to DSM-5 criteria
- years of age or older
- Fluent enough in English to participate in group
- Willing to abstain from using medications for ED (i.e., PDE5 inhibitors, intracavernosal injections, MUSE etc.) from the start of treatment until the 1-month follow-up (totaling 10 weeks)
- Comfortable and interested in participating in a small group format with 6-10 others
You may not qualify if:
- This study is not suitable for individuals who:
- Do not experience an exacerbation of ED in the partnered context
- Have a current unmanaged health condition (e.g., unmanaged diabetes mellitus) or unstable mental health condition (e.g., severe depression/anxiety, active suicidal ideation) that would interfere with self- or partnered-sexual activities or with group participation
- Do no feel comfortable participating in a small group format with 6-10 others
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9, Canada
Related Publications (1)
Bossio JA, Basson R, Driscoll M, Correia S, Brotto LA. Mindfulness-Based Group Therapy for Men With Situational Erectile Dysfunction: A Mixed-Methods Feasibility Analysis and Pilot Study. J Sex Med. 2018 Oct;15(10):1478-1490. doi: 10.1016/j.jsxm.2018.08.013.
PMID: 30297094RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miriam Driscoll, MD
UBC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PI
Study Record Dates
First Submitted
June 27, 2019
First Posted
April 10, 2020
Study Start
April 14, 2020
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
October 19, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share